Replies to post #78424 on Biotech Values

[DewDiligence]

HEB – Tuesday was the PDUFA date for Ampligen, but the FDA isn’t ready to act:

http://finance.yahoo.com/news/Hemispherx-Biopharma-pz-15344715.html

Amusingly, HEB shares finished the day +23% on the theory that any words from the FDA other than “get lost” should be construed as bullish.

[DewDiligence]

HEB can’t be bothered with waiting for the delayed FDA decision on the Ampligen BLA—instead, they are paying out executive bonuses right now:

http://finance.yahoo.com/news/Hemispherx-Announces-Payment-pz-15357167.html

LMAO